Advertisement
Health

Devonian Health Group Inc. to Participate in Three Renmark’s Virtual Non-Deal Roadshow Series

Advertisement

Advertisement

QUEBEC CITY–()–Devonian Well being Group Inc. (“Devonian” or the “Company”) (TSXv: GSD; OTCQB: DVHGF), a medical stage botanical pharmaceutical company, targeted on growing a singular portfolio of botanical pharmaceutical and cosmeceutical merchandise, introduced in the present day that they are going to be taking part in three Renmark Monetary Communications Inc.’s dwell Digital Non-Deal Roadshow Collection to debate the newest investor presentation.

Roadshow Collection Occasion Full Schedule:

Advertisement

New York, USA: Tuesday, October 25, at 10:00 AM EDT

Boston, USA: Thursday, November 10, at 12:00 PM EDT

Toronto, Canada: Thursday, December 8, at 12:00 PM EDT.

The presentation will function President & CEO Pierre Montanaro and Chief Scientific Officer Dr. André P. Boulet. Subjects to be lined will embody the newest company investor presentation adopted by a dwell Q&A. Buyers eager about taking part on this occasion might want to register utilizing the hyperlink beneath. As a reminder, registration for the dwell occasion could also be restricted, however entry to the replay after the occasion might be on the corporate’s investor web page (www.groupedevonian.com).

Devonian welcomes stakeholders, buyers, and different particular person followers to register and attend this dwell occasion.

REGISTER HERE:

New York Metropolis , Tuesday, October 25, 2022:

https://www.renmarkfinancial.com/events/renmark-virtual-non-deal-roadshow-tsx-v-gsd-otcqb-dvhgf-2022-10-25-100000

Boston, Thursday, November 10, 2022:

https://www.renmarkfinancial.com/events/renmark-virtual-non-deal-roadshow-tsx-v-gsd-otcqb-dvhgf-2022-11-10-120000

Toronto, Thursday, December 8, 2022:

https://www.renmarkfinancial.com/events/renmark-virtual-non-deal-roadshow-tsx-v-gsd-otcqb-dvhgf-2022-12-08-120000

To make sure clean connectivity, please entry this hyperlink utilizing the newest model of Google Chrome.

About Devonian

Devonian Well being Group Inc. (Devonian)is a late-stage botanical pharmaceutical company with novel therapeutic approaches to focusing on unmet medical wants. Devonian’s core technique is to develop prescription botanical medication from plant supplies and algae for the remedy of inflammatory-autoimmune ailments together with however not restricted to ulcerative colitis and atopic dermatitis. Based mostly on a basis of over 15 years of analysis, Devonian’s focus is additional supported by a US-FDA set of regulatory tips favouring a extra environment friendly drug growth pathway for prescription botanical drug merchandise over these of conventional prescription medicines. Devonian’s flagship product, Thykamine™, the primary pharmaceutical product issued from Devonian’s SUPREX™ platform, is a extremely progressive product for the prevention and remedy of well being circumstances associated to irritation and oxidative stress. The anti-inflammatory, anti-oxidative and immunomodulatory properties of Thykamine™ have been demonstrated by a substantial variety of in vitro and in vivo research in addition to in a Section IIa medical examine in sufferers with Delicate-to-Reasonable distal Ulcerative Colitis and in a big section 2 medical trial in grownup sufferers with Delicate-to-Reasonable Atopic Dermatitis.

Devonian can also be concerned within the growth of high-value cosmeceutical merchandise leveraging the identical proprietary strategy employed with their pharmaceutical choices. Devonian Well being Group Inc. was integrated in 2015 and is headquartered in Québec, Canada the place it owns a state-of-the artwork extraction facility with full traceability ‘from the seed to the tablet’. Acquired in 2018, Altius Healthcare Inc., its commercialization subsidiary, brings alternatives for additional diversification and development potential. Devonian is listed on the TSX Enterprise Trade (TSXV:GSD) in addition to the OTCQB Enterprise Trade (OTCQB:DVHGF)

For extra data, go to www.groupedevonian.com

About Renmark Monetary Communications Inc.

Based in 1999, Renmark Monetary Communications Inc. is North America’s main retail investor relations agency. Using a strategic and complete mixture of publicity techniques; Renmark hosts Digital Non-Deal Roadshows in addition to in-person company shows and maintains day by day communications with hundreds of brokers and cash managers throughout Canada and the USA. Renmark empowers its publicly traded clientele to maximise their visibility throughout the monetary group and strengthen their investor viewers.


Source link

Related Articles

Back to top button